Search

everythinglearnresearchcommunity

for

Search:↓

Androgen deprivation therapy might help prevent severe COVID-19, but more research is needed.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

The conclusion is that tritium-labeled testosterone metabolites can be made and are better converted into dihydrotestosterone in skin cells than in prostate tissue.

Piper cubeba and Aquilaria sinensis may help prevent or treat prostate issues by balancing hormones.

Finasteride is effective for hair loss and may help prevent prostate cancer without increasing high-grade cancer risk.

Finasteride is beneficial for BPH but requires careful monitoring due to cancer risks.

A new compound that could treat various androgen-related conditions was created and analyzed.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

Dutasteride is slightly better than finasteride for treating BPH but has fewer sexual side effects.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

Androgen levels can increase at any age, affecting symptoms like acne, hair loss, and prostate size.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Finasteride and dutasteride may lower melanoma risk, with teenage acne possibly indicating higher risk.

Unripe Rubus occidentalis extracts may help treat benign prostatic hyperplasia.

Finasteride reduces low-grade prostate cancer but may not be beneficial overall.

Testosterone changes reduce thyroxin levels in rats.

A new compound was made that might help treat diseases related to male hormones.

PSA levels help determine prostate size and guide treatment choices for benign prostatic hyperplasia.

Systematic end-of-trial biopsies are the most reliable way to assess outcomes.

Combination therapy for BPH is more effective in certain men but may not be cost-effective due to minimal impact and potential side effects.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Male pattern baldness is common, treatable, and may be linked to heart disease and prostate cancer.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men.

Finasteride reduces sperm count and affects male reproductive function, while Epristeride does not.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

Researchers developed a method to measure different forms of a drug that could help treat prostate issues and hair loss, and found how these forms behave in animals.

Agomelatine may help reduce benign prostatic hyperplasia by blocking certain inflammatory pathways.